Clinical Trial Update: Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics [Phase 3]

View source ↗

Summary

This document provides a Phase 3 trial update on Aridol for detecting bronchial hyperresponsiveness in suspected asthma patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Aridol (mannitol)

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 3 | Status: COMPLETED